The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Vertex Pharmaceuticals announced that Journavx will be priced at $15.50 per pill.The FDA-approved medication, available as a 50-milligram prescription tablet taken every 12 hours, offers a non ...

Journavx was found to be as similarly effective as hydrocodone, an opioid pain medication, for reducing acute pain, with the added benefit of being a non-opioid and non-addictive drug.

Journavx showed a “statistically significant superior reduction in pain” when compared to a placebo in two randomized trials of acute surgical pain, according to the FDA.

The Food and Drug Administration on Thursday approved Journavx, a non-opioid painkiller that is the first novel pain drug to win government authorization in more than 20 years. Vertex ...

The FDA's approval process for Journavx included an evaluation of its safety and efficacy. Clinical trials demonstrated that the drug is effective in managing acute pain without the adverse ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a press release.The nonopioid analgesic suzetrigine (Journavx, Vertex ...

FDA approves Journavx, the first new painkiller in over two decades. The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

FDA Approves New Non-Opioid Painkiller, Journavx: 'No Addiction Potential' A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous By ...

Among the patients who received Journavx in the clinical trials was a 50-year-old woman from the Atlanta area. She had a nose job in October 2023 and began taking the pill immediately afterward in ...